⌘K

Home/Filings/4/0000899243-21-021838

4//SEC Filing

Daniel Thomas O 4

Accession 0000899243-21-021838

CIK 0001690585other

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 6:30 PM ET

Size

5.4 KB

Accession

0000899243-21-021838

Insider Transaction Report

Form 4

Period: 2021-06-01

Magenta Therapeutics, Inc.MGTA

Daniel Thomas O

Director

Transactions

Award
Stock Option (Right to Buy)
2021-06-01+18,188→ 18,188 total
Exercise: $12.91Exp: 2031-05-31→ Common Stock (18,188 underlying)

Footnotes (1)

[F1]This option shall vest and become exercisable in full upon the earlier to occur of (a) June 1, 2022 or (b) the next annual meeting of the Issuer's stockholders.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Magenta Therapeutics, Inc.

CIK 0001690585

Entity typeother

Related Parties

1

filerCIK 0001538894

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 6:30 PM ET
Size: 5.4 KB

View on SEC.gov